|
SPIRE1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.689600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.693800E-01 |
| Normal-vs-Stage2 |
7.960400E-01 |
| Normal-vs-Stage3 |
3.573400E-01 |
| Normal-vs-Stage4 |
8.260400E-01 |
| Stage1-vs-Stage2 |
8.796600E-01 |
| Stage1-vs-Stage3 |
7.075000E-01 |
| Stage1-vs-Stage4 |
7.299200E-01 |
| Stage2-vs-Stage3 |
6.472200E-01 |
| Stage2-vs-Stage4 |
7.138600E-01 |
| Stage3-vs-Stage4 |
4.732000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.655820E-01 |
| Normal-vs-AfricanAmerican |
6.153400E-01 |
| Normal-vs-Asian |
3.343600E-01 |
| Caucasian-vs-AfricanAmerican |
2.919600E-01 |
| Caucasian-vs-Asian |
5.793000E-01 |
| AfricanAmerican-vs-Asian |
5.124000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.648500E-02 |
| Normal-vs-Female |
1.401010E-01 |
| Male-vs-Female |
1.032100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.088800E-01 |
| Normal-vs-Extreme_Weight |
1.241600E-02 |
| Normal-vs-Obese |
8.782800E-01 |
| Normal-vs-Extreme_Obese |
7.478600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.116800E-01 |
| Normal_Weight-vs-Obese |
5.993200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.672600E-01 |
| Extreme_Weight-vs-Obese |
7.517600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.665800E-01 |
| Obese-vs-Extreme_Obese |
7.790200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.335200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.883800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.762800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.385300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.520600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.489600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.693900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.273200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.117300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.112300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.120220E-02 |
| Normal-VS-Type2 PRCC |
5.800400E-01 |
| Normal-VS-KIRP CIMP |
1.236360E-01 |
| Normal-VS-Unclassified PRCC |
9.789500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.757600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.236700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.582400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.708800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.609650E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.443100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.410100E-02 |
| Normal-vs-N1 |
7.355000E-01 |
| Normal-vs-N2 |
9.841400E-01 |
| N0-vs-N1 |
1.476180E-01 |
| N0-vs-N2 |
5.932200E-01 |
| N1-vs-N2 |
8.764200E-01 |
|
|
